Alembic Pharma JV Aleor gets USFDA nod for generic antifungal cream

New Delhi: Drug firm Alembic Pharmaceuticals on Thursday said its joint venture Aleor Dermaceuticals has received final nod from the US health regulator for antifungal Nystatin and Triamcinolone Acetonide cream used for the treatment of cutaneous candidiasis. Aleor Dermaceuticals Ltd (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Nystatin and Triamcinolone Acetonide cream USP, 1,00,000 units/gram and 1 mg/gram, Alembic Pharma said in a BSE filing.

The product is a generic version of Taro Pharmaceuticals USA Inc’s Nystatin and Triamcinolone Acetonide cream USP in the same strength, it added.

According to IQVIA, Nystatin and Triamcinolone Acetonide cream USP has an estimated market size of USD 19 million for twelve months ending December 2020, the filing said.

  • Related Posts

    KGMU to file FIR against 4 employees over Rs 2.5 crore medicine procurement irregularities

    Lucknow: King George’s Medical University (KGMU) will file an FIR against four employees after a probe found alleged irregularities worth around Rs 2.5 crore in medicines procurement under the Asadhya…

    Haryana Launches ‘Make in Haryana Industrial Policy’

    Gurugram: Haryana moved to sharpen its pitch as one of India’s most competitive industrial and investment destinations as Chief Minister Nayab Singh Saini launched the Make in Haryana Industrial Policy 2026…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    KGMU to file FIR against 4 employees over Rs 2.5 crore medicine procurement irregularities

    KGMU to file FIR against 4 employees over Rs 2.5 crore medicine procurement irregularities

    Haryana Launches ‘Make in Haryana Industrial Policy’

    Haryana Launches ‘Make in Haryana Industrial Policy’

    A new pancreatic cancer pill may be a game changer for patients

    A new pancreatic cancer pill may be a game changer for patients

    NPPA fixes prices of 30 drugs including Vitamin D3, calcium supplements

    NPPA fixes prices of 30 drugs including Vitamin D3, calcium supplements

    Maharashtra FDA seizes ₹73 lakh worth of medicines in crackdown on misleading health claims in ads

    Maharashtra FDA seizes ₹73 lakh worth of medicines in crackdown on misleading health claims in ads

    Industry asks NPPA to implement SOTS Scheme to resolve pending litigations

    Industry asks NPPA to implement SOTS Scheme to resolve pending litigations